Hyperparathyroidism but a negative sestamibi scan: A clinical dilemma

Gavin T. Slitt, Hugh Lavery, Anthony Morgan, Bruce Bernstein, James Slavin, Mozaferiddin K. Karimeddini, Robert Kozol

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: The outcomes of patients with biochemically confirmed hyperparathyroidism but a negative Tc-99 Sestamibi scan are unclear. We examined the outcomes and quality of life of patients having surgery and those who had medical therapy. Methods: Patients having a diagnosis of hyperparathyroidism with confirmed elevated calcium and parathormone levels, yet negative sestamibi scans were identified. The RAND SF-36 Health Survey was administered via mail to these patients. The patient's charts were then reviewed to verify treatments and to determine outcomes. Results: Ninety-five patients fitting the criteria were identified. Twenty patients completed all aspects of the study. Ten of the respondents had undergone parathyroidectomy, and 10 had not. The surgical patients scored more favorably in all 8 of the measured parameters than patients treated medically. The differences in 3 domains, physical functioning, pain, and social functioning, were statistically significant. Conclusions: Our findings suggest that surgical therapy confers a better quality of life and is superior to medical therapy in the treatment of primary hyperparathyroidism, even in patients having a negative sestamibi scan.

Original languageEnglish
Pages (from-to)708-712
Number of pages5
JournalAmerican Journal of Surgery
Volume190
Issue number5
DOIs
StatePublished - Nov 1 2005
Externally publishedYes

Fingerprint

Hyperparathyroidism
Quality of Life
Therapeutics
Parathyroidectomy
Primary Hyperparathyroidism
Postal Service
Health Surveys
Parathyroid Hormone
Calcium
Pain

Keywords

  • HPT
  • Parathyroid glands
  • Sestamibi scan
  • SF-36

ASJC Scopus subject areas

  • Surgery

Cite this

Slitt, G. T., Lavery, H., Morgan, A., Bernstein, B., Slavin, J., Karimeddini, M. K., & Kozol, R. (2005). Hyperparathyroidism but a negative sestamibi scan: A clinical dilemma. American Journal of Surgery, 190(5), 708-712. https://doi.org/10.1016/j.amjsurg.2005.07.007

Hyperparathyroidism but a negative sestamibi scan : A clinical dilemma. / Slitt, Gavin T.; Lavery, Hugh; Morgan, Anthony; Bernstein, Bruce; Slavin, James; Karimeddini, Mozaferiddin K.; Kozol, Robert.

In: American Journal of Surgery, Vol. 190, No. 5, 01.11.2005, p. 708-712.

Research output: Contribution to journalArticle

Slitt, GT, Lavery, H, Morgan, A, Bernstein, B, Slavin, J, Karimeddini, MK & Kozol, R 2005, 'Hyperparathyroidism but a negative sestamibi scan: A clinical dilemma', American Journal of Surgery, vol. 190, no. 5, pp. 708-712. https://doi.org/10.1016/j.amjsurg.2005.07.007
Slitt GT, Lavery H, Morgan A, Bernstein B, Slavin J, Karimeddini MK et al. Hyperparathyroidism but a negative sestamibi scan: A clinical dilemma. American Journal of Surgery. 2005 Nov 1;190(5):708-712. https://doi.org/10.1016/j.amjsurg.2005.07.007
Slitt, Gavin T. ; Lavery, Hugh ; Morgan, Anthony ; Bernstein, Bruce ; Slavin, James ; Karimeddini, Mozaferiddin K. ; Kozol, Robert. / Hyperparathyroidism but a negative sestamibi scan : A clinical dilemma. In: American Journal of Surgery. 2005 ; Vol. 190, No. 5. pp. 708-712.
@article{81f555074d104c0a8a8cb16e53ec2578,
title = "Hyperparathyroidism but a negative sestamibi scan: A clinical dilemma",
abstract = "Background: The outcomes of patients with biochemically confirmed hyperparathyroidism but a negative Tc-99 Sestamibi scan are unclear. We examined the outcomes and quality of life of patients having surgery and those who had medical therapy. Methods: Patients having a diagnosis of hyperparathyroidism with confirmed elevated calcium and parathormone levels, yet negative sestamibi scans were identified. The RAND SF-36 Health Survey was administered via mail to these patients. The patient's charts were then reviewed to verify treatments and to determine outcomes. Results: Ninety-five patients fitting the criteria were identified. Twenty patients completed all aspects of the study. Ten of the respondents had undergone parathyroidectomy, and 10 had not. The surgical patients scored more favorably in all 8 of the measured parameters than patients treated medically. The differences in 3 domains, physical functioning, pain, and social functioning, were statistically significant. Conclusions: Our findings suggest that surgical therapy confers a better quality of life and is superior to medical therapy in the treatment of primary hyperparathyroidism, even in patients having a negative sestamibi scan.",
keywords = "HPT, Parathyroid glands, Sestamibi scan, SF-36",
author = "Slitt, {Gavin T.} and Hugh Lavery and Anthony Morgan and Bruce Bernstein and James Slavin and Karimeddini, {Mozaferiddin K.} and Robert Kozol",
year = "2005",
month = "11",
day = "1",
doi = "10.1016/j.amjsurg.2005.07.007",
language = "English",
volume = "190",
pages = "708--712",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Hyperparathyroidism but a negative sestamibi scan

T2 - A clinical dilemma

AU - Slitt, Gavin T.

AU - Lavery, Hugh

AU - Morgan, Anthony

AU - Bernstein, Bruce

AU - Slavin, James

AU - Karimeddini, Mozaferiddin K.

AU - Kozol, Robert

PY - 2005/11/1

Y1 - 2005/11/1

N2 - Background: The outcomes of patients with biochemically confirmed hyperparathyroidism but a negative Tc-99 Sestamibi scan are unclear. We examined the outcomes and quality of life of patients having surgery and those who had medical therapy. Methods: Patients having a diagnosis of hyperparathyroidism with confirmed elevated calcium and parathormone levels, yet negative sestamibi scans were identified. The RAND SF-36 Health Survey was administered via mail to these patients. The patient's charts were then reviewed to verify treatments and to determine outcomes. Results: Ninety-five patients fitting the criteria were identified. Twenty patients completed all aspects of the study. Ten of the respondents had undergone parathyroidectomy, and 10 had not. The surgical patients scored more favorably in all 8 of the measured parameters than patients treated medically. The differences in 3 domains, physical functioning, pain, and social functioning, were statistically significant. Conclusions: Our findings suggest that surgical therapy confers a better quality of life and is superior to medical therapy in the treatment of primary hyperparathyroidism, even in patients having a negative sestamibi scan.

AB - Background: The outcomes of patients with biochemically confirmed hyperparathyroidism but a negative Tc-99 Sestamibi scan are unclear. We examined the outcomes and quality of life of patients having surgery and those who had medical therapy. Methods: Patients having a diagnosis of hyperparathyroidism with confirmed elevated calcium and parathormone levels, yet negative sestamibi scans were identified. The RAND SF-36 Health Survey was administered via mail to these patients. The patient's charts were then reviewed to verify treatments and to determine outcomes. Results: Ninety-five patients fitting the criteria were identified. Twenty patients completed all aspects of the study. Ten of the respondents had undergone parathyroidectomy, and 10 had not. The surgical patients scored more favorably in all 8 of the measured parameters than patients treated medically. The differences in 3 domains, physical functioning, pain, and social functioning, were statistically significant. Conclusions: Our findings suggest that surgical therapy confers a better quality of life and is superior to medical therapy in the treatment of primary hyperparathyroidism, even in patients having a negative sestamibi scan.

KW - HPT

KW - Parathyroid glands

KW - Sestamibi scan

KW - SF-36

UR - http://www.scopus.com/inward/record.url?scp=26844542533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26844542533&partnerID=8YFLogxK

U2 - 10.1016/j.amjsurg.2005.07.007

DO - 10.1016/j.amjsurg.2005.07.007

M3 - Article

C2 - 16226944

AN - SCOPUS:26844542533

VL - 190

SP - 708

EP - 712

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 5

ER -